Evidence map›Paper›PMID 39360426›Full record

ArticleJournal of the International Association of Providers of AIDS Care

Sociodemographic and Clinical Predictors of Weight Gain During the First Year of Antiretroviral Therapy among Adults Living With HIV in Urban Tanzania.

Pilly Chillo, Alfa Muhihi, Goodarz Danaei, Muhammad Bakari, Gideon Kwesigabo, Marina Njelekela, Nzovu Ulenga, Wafaie W Fawzi, Ferdinand Mugusi, Christopher R Sudfeld

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the International Association of Providers of AIDS Care. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Pilly ChilloDepartment of Internal Medicine, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.ORCID 0000-0001-7073-1122
Alfa MuhihiAfrica Academy for Public Health, Dar es Salaam, Tanzania.
Goodarz DanaeiDepartment of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Muhammad BakariDepartment of Internal Medicine, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Gideon KwesigaboDepartment of Epidemiology and Biostatistics, School of Public Health and Social Sciences, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania.
Marina NjelekelaDepartment of Physiology, Muhimbili University of Health and Allied Sciences and Deloitte Consulting Limited, Dar Es Salaam, Tanzania.
Nzovu UlengaManagement and Development for Health, Dar es Salaam, Tanzania.
Wafaie W FawziDepartment of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Ferdinand MugusiDepartment of Internal Medicine, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Christopher R SudfeldDepartment of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Funding

Training Tanzanian Researchers for HIV/AIDS Implementation ScienceD43TW009775 · FIC · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Wafaie W Fawzi, Christopher Sudfeld · 2015 to 2026
$3.0M
Trial of Vitamin D in HIV ProgressionR01DK098075 · NIDDK · HARVARD SCHOOL OF PUBLIC HEALTH · PI FAWZI, WAFAIE W · 2013 to 2017
$2.6M
FIC NIH HHS D43 TW009775NIDDK NIH HHS R01 DK098075
6 · The paper itself

Abstract

Antiretroviral therapy (ART) has improved the survival of people living with HIV (PLHIV) but this success has been accompanied by an increase in noncommunicable diseases. We conducted a prospective cohort study of 4000 adult PLHIV who were initiating ART in Dar es Salaam, Tanzania, to assess weight gain during the first year of treatment and associated sociodemographic and clinical factors. Anthropometric data were collected at ART initiation and monthly follow-up visits. The mean weight gain during the first year of treatment was 2.6 ± 0.3 kg, and the prevalence of overweight or obesity increased from 26.3% at baseline to 40.7%. Female sex, greater household wealth, lower CD4-T-cell counts, higher WHO HIV disease stage, and pulmonary tuberculosis were associated with a greater increase in body mass index (

Indexed as

HIV InfectionsWeight GainAdultAnti-HIV AgentsAnti-Retroviral AgentsBody Mass IndexCD4 Lymphocyte CountFemaleHumansMaleMiddle AgedObesityOverweightProspective StudiesTanzaniaUrban PopulationAnti-HIV AgentsAnti-Retroviral Agentshighly active antiretroviral therapyHIVnutritional statusTanzaniaweight gain

Identifiers

PMID39360426
PMCPMC11462572

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.